Insights into the development of Stress-induced T2D: Adenocorticotrophic hormone (ACTH) suppresses the expression of a positive regulator of insulin transcription, NeuroD1 via up regulation of its target gene, 6/September/2014, 05.35 am

Anti-metastatic therapy: Tumorsuppressor MiRNA-7 suppresses the expression of WASF3 via down regulation of its target gene, 06/September/2014, 0.5.21 am
September 5, 2014
Molecular therapy for Osteoporosis: The stem cell protein Oct-4 suppresses the expression of a bone formation inhibitor Sclerostin via down regulation of its target gene, 6/September/2014, 05.43 am
September 6, 2014
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Insights into the development of Stress-induced T2D: Adenocorticotrophic hormone (ACTH) suppresses the expression of a positive regulator of insulin transcription, NeuroD1 via up regulation of its target gene, 6/September/2014, 05.35 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Significance:  Prolonged physical/mental/emotional/environmental stress can induce ACTH. This in turn can induce its downstream target genes.  This study suggests, for the first time, that stress responsive protein ACTH, by decreasing its downstream target gene, it may decrease the expression of an activator of insulin transcription, NeuroD1.  This data suggests that “ACTH inhibitors” may be used to treat stress-induced T2D.

Comments are closed.